Hunan Kelun Pharmaceutical Co., Ltd.

This early-stage study tests whether a new drug called KLA318-2 is safe and how the body processes it. About 48 healthy adults aged 18-45 will receive a single injection and be monitored for side effects and drug levels. No treatment or cure is being tested—only safety and drug b…

This early-stage study tests the safety and how the body handles a new drug called KLA578-1. It involves 48 healthy adults aged 18 to 45. The goal is to check for side effects and measure drug levels in the blood, not to treat any disease.

This early-stage study is testing a new drug, KLA478, in 40 healthy adults aged 18 to 45. The main goal is to see if the drug is safe and how the body processes it. Participants receive a single dose and are monitored for side effects and drug levels in the blood. No treatment fo…